We performed mutation signature analysis, to define whether defective FEN1 methylation (R192Q) or defective FEN1 demethylation (Jmjd1b−/−) causes a unique mutation signature and whether their mutation signatures correspond to those identified in human cancers. This evidence concerns the gene FEN1 and cancer.